Direxion Daily S&P Biotech Bear 3X ETF
LABD
12 hedge funds and large institutions have $9.23M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
168% more call options, than puts
Call options by funds: $1.68M | Put options by funds: $628K
10% more capital invested
Capital invested by funds: $8.41M → $9.23M (+$817K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$2.5M |
| 2 |
Morgan Stanley
New York
|
+$2.14M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.3M |
| 4 |
VF
Virtu Financial
New York
|
+$1.14M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$139K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$5.69M |
| 2 |
Jane Street
New York
|
-$368K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$269K |
| 4 |
CT
CMT Trading
Chicago,
Illinois
|
-$9.96K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$9.96K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
SG Americas Securities
New York
| $3.85M | +$2.5M | +251 | +150% |
|
|
2
Morgan Stanley
New York
| $1.98M | +$2.14M | +215 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.27M | +$1.3M | +131 | +1,871% |
|
|
VF
4
Virtu Financial
New York
| $1.17M | +$1.14M | +114 | +877% |
|
5
Barclays
London,
United Kingdom
| $277K | – | – | – |
|
|
HF
6
HRT Financial
New York
| $181K | +$19.9K | +2 | +11% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $175K | -$269K | -27 | -59% |
|
|
8
Citadel Advisors
Miami,
Florida
| $130K | +$139K | +14 | New |
|
|
CT
9
CMT Trading
Chicago,
Illinois
| $72K | -$9.96K | -1 | -11% |
|
10
Goldman Sachs
New York
| $71K | – | – | – |
|
|
11
Citigroup
New York
| $39K | -$5.69M | -571 | -99% |
|
|
CG
12
Cutler Group
San Francisco,
California
| $12K | -$9.96K | -1 | -50% |
|
|
13
Jane Street
New York
| – | -$368K | -37 | Closed |
|
14
Simplex Trading
Chicago,
Illinois
| – | -$8K | -1 | Closed |
|
|
TWA
15
TCI Wealth Advisors
Tucson,
Arizona
| – | -$2K | – | – |
|
LABD Hedge Fund Activity: Q4 2017 in Review
12 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2017, worth a combined $9.23M — up 9.7% from $8.41M a quarter earlier.
Fund positioning in LABD was balanced in Q4 2017: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was SG Americas Securities, adding an estimated $2.5M. The largest seller was Citigroup, cutting an estimated $5.69M.
- 12 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $9.23M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2017, up 9.7% quarter-over-quarter.
- 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2017 and 2 closed out, a net change of 0 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2017 was SG Americas Securities, an estimated $2.5M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2017 was Citigroup, an estimated $5.69M sold.
Based on aggregated 13F filings for Q4 2017.